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Objective: To determine the frequency of various Inherited Metabolic Diseases (IMDs) in clinically suspected 
neonates and children in relation to age, gender, and distribution in rural and urban areas. 
Materials and Methods: A total of 275 symptomatic neonates and children were enrolled for IMDs. A complete 
medical history, baseline biochemical tests, cerebrospinal fluid analysis, arterial blood gases, anion gap, serum 
ammonia, lactate, and urinary ketones were assessed. Any significant microbiological cause for the presenting 
symptom was excluded. For screening of Inborn Metabolic Error simple Heel prick test was done on PerkinElmer 
226 filter paper in newborns and infants. Samples were sent to Jordan for analysis. High-performance liquid 
chromatography combined with tandem mass spectrometry (LC-MS/MS) was the technique used in the screening 
of a variety of IMDs. The frequency of Inherited Metabolic Diseases and their relation with age, gender, and 
location was determined using the chi-square goodness of fit test. A p-value ≤ of 0.05 was considered statistically 
significant.  
Results: Of the 275 subjects screened, 47(17%) had an inherited metabolic disorder, of which 27 were male and 20 
were female with a Male to Female ratio of 1.35:1. The difference in metabolic disorders was significantly different 
between age (p=0.01) and gender (p=0.04). Of the diagnosed cases G6PD disorder was found to be the most 
frequent disorder 14 (29.79%) of the total diagnosed cases, followed by Aminoaciduria in 9 (19.15%) and Carnitine 
Uptake Defect in 7 (14.8).  
Conclusion: The cases detected to have IMDs revealed a significant prevalence. G6PD was detected as the most 
frequent disorder. A simple Heel prick test on PerkinElmer 226 filter paper is a useful method to detect IMDs, 
though confirmation is usually required by other tests.   















Inherited Metabolic Diseases (IMDs) are a variety of 
clinical conditions occurring due to the lack of a single 
enzyme or transporter in a metabolic pathway. This 
leads to the accumulation of toxic intermediate 
metabolites in the body of a neonate.1 The buildup of 
such metabolites leads to clinical symptoms such as 
vomiting, lethargy, hypotonia, tachypnea, convulsions, 
developmental delay, or mental retardation. Most of 
these disorders usually manifest during the first week 
of birth when the infant starts feeding. Nevertheless if 
undiagnosed at this stage they present later along with 
other severe conditions such as sepsis, 
encephalopathy, pulmonary hemorrhage, metabolic 
acidosis, and seizure. The treatment at this stage 
becomes very difficult and challenging.2  
So far over 1000 inherited metabolic diseases/inborn 
errors of metabolism (IEMs) have been stated and 
among them, 200 of such illnesses can be treated if 
diagnosed early.3 Over the past decades the genetic 
defects of numerous inherited metabolic diseases have 
been recognized. Novel treatment options are now in 
hand and have enhanced the life expectancy for 
several patients with inherited metabolic diseases.4 
Global statistics have shown that IEMs related 
mortality rate is 33% or more in low and middle-
income countries, causing at least 23529 annual 
casualties which internationally contribute a share of 
0.4% to the global child mortality.5 
Most of these disorders are diagnosed through 
screening programs in newborns recognized in many 
developed countries.  Pakistan is a developing country 
with a population of more than 220 million and 
unfortunately does not have any screening program 
devised for newborns at the local or national level to 
date. There are few studies conducted in Pakistan on 
the local population on the subject because a very 
small number of centers are currently offering 
diagnostic facilities for specific metabolites.3 Disorders 
of IEM must be detected and treated as early as 
possible. Lack of diagnostic facilities is a contributing 
factor in the delay in the treatment of these illnesses. 
Neonatal screening plays an important role in early 
diagnosis, and the use of tandem mass spectrometry 
has increased the number of diseases that can be 
detected.6 
Tandem mass spectrometry is a standard technique 
used for screening more than 50 metabolic disorders in 
newborns which have made the diagnosis of IEMs 
more efficient. It has improved specificity and 
sensitivity for dried blood spot analysis. High-
performance liquid chromatography combined with 
tandem mass spectrometry (LC-MS/MS) is an 
analytical instrument with a high turnover of tests. It 
can detect amino acid and fatty acid disorders within a 
very short time. Detection of these two metabolic 
components helps in the screening of more than 50 
metabolic disorders.7 As a most recent advancement, 
genetic technology is more helpful for newborn 
screening of IMDs in newborns.8 Genetic mutations are 
the focal error in all metabolic diseases Therefore, 
precise genetic analysis is mandatory for the patient 
before proceeding for treatment.9 
This study aimed to screen suspected cases of IEMs in 
clinically suspected neonates and children in NICU 
and pediatrics OPD of  Izzat Ali Shah Hospital Wah 
Cantt along with their relation to age, gender, and 
distribution in rural and urban areas.      
 
Materials and Methods 
 
Study design and study population: 
This descriptive cross-sectional study was carried out 
conducted at the NICU and Paediatrics OPD of  Izzat 
Ali Shah Hospital, Wah Cantt. from Sept 2017 to 
March 2020. The study was approved by the ethics 
committee of the hospital and the informed written 
consent was taken from the parents of all participants. 
A total of 275 neonates and children were enrolled 
with ages ranging from 1 day to 11 years. Patients with 
symptoms like reluctance to feed, vomiting, 
hypoglycemia, metabolic acidosis, hypotonia, and 
refractory seizures were included in the study. They 
also had a history of previous unexplained death in 
the siblings. Investigations conducted at the hospital 
laboratory included complete blood picture, blood 
cultures, C-reactive protein, liver, and kidney function 
tests, serum electrolytes, PT/APTT, cerebrospinal fluid 
analysis, arterial blood gases, anion gap, serum 
ammonia, and lactate and urinary ketones. Any 
significant microbiological cause for the presenting 
symptom was excluded. Neuro-imaging was done in 
some cases to exclude any cause for symptoms relating 
to CNS disorders. In order to exclude IEM simple Heel 
prick test was done on PerkinElmer 226 filter paper in 
newborns and infants. This paper was provided by 
Zahra Beau (ZB) Foundation. As the screening of 
Inherited Metabolic Diseases (IMDs) is expensive in 
Pakistan so this diagnostic facility was provided by the 
ZB foundation on a charity basis. All the samples were 
sent to Med Labs, Jordan for analysis by ZB 
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Foundation. High performance liquid chromatography 
combined with tandem mass spectrometry (LC-
MS/MS) was the technique used in the screening of 
these cases. Sampling was done for screening of 
primary disorders such as Galactosemia, Cystic 
fibrosis, congenital hypothyroidism, congenital 
adrenal hyperplasia, phenylketonuria, glucose 
6phosphate dehydrogenase (G6PD), sickle cell anemia, 
and other hemoglobinopathies. Also, screening for 
fatty acid oxidation disorders (e.g. Carnitine uptake 
defect), organic acid disorders (e.g. Malonic acidemia, 
Propionic aciduria), amino acid disorders (e.g. Maple 
syrup urine disease, homocystinuria), and lysosomal 
storage diseases were done. 
Data was collected and analyzed using SPSS version 
19. A p-value < 0.05 was considered significant. The 
frequency of Inherited Metabolic Diseases in 47 
subjects was calculated and its relation with age, 




Out of 275, 47 (17%) patients were tested positive for 
either one or two metabolic diseases. The difference in 
metabolic disorders was statistically significant 
between males and females: X2=4.235, p=0.04, more 
common in males 27 (57.4%) than females 20 (42.5%). 
17-OH Progesterone deficiency, Cystic Fibrosis, and 
Carnitine uptake defects were more common in males. 
Whereas Galactosemia, organic acid disorders, 17-OH 
Progesterone deficiency & Malonic Acidemia were 
more common in females (Figure 1). 
The age of these patients ranged from 2 days to 6.5 
years. Cystic fibrosis with Carnitine uptake defect and 
with G6PD deficiency was more common in patients 
with age less than 60 days and Aminoaciduria was 
more common in patients with age more than 60 days. 
The difference in the distribution of metabolic 
disorders in different age groups was statistically 
significant: X2=6.618, p=0.01(Table 1), with higher 
frequency in age >60 days (Figure 2). The difference is 
also significant in terms of gender (p=0.04). 
Our study included 26 patients from the rural and 21 
patients from the urban area. G6PD deficiency was 
common in both patients coming from rural or urban 
areas. Patients belonging to urban areas had more 
incidence of combined defect of cystic fibrosis and 
G6PD deficiency. Whereas patients from rural areas 
presented with a sole disorder of 17-OH Progesterone 
deficiency and organic acid disorders. They had 
combined metabolic errors in Cystic Fibrosis and 
Carnitine uptake, 17-OH progesterone, and Malonic 
academia (Figure 3). The place of residence had no 
relation with the IMDs in children; X2=0.265, p=0.607. 
 
Table 1: Chi-square test goodness of fit test showing 
association of IEM with Age. Gender & Location of 
patients 
Variable  Chi-square value P-value 
Gender 4.235 0.04 
Age 6.618 0.01 
Location 0.265 0.607 
 
 
Figure 1: The statistical analysis of IMDs between 
male and female cases (n=47) 
 
 
Figure 2: The statistical analysis of IMDs in relation 
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Figure 3: The statistical analysis of IMDs between 




Inherited metabolic diseases (IMDs) or Inborn errors 
of metabolism (IEMs) are characteristic clinical 
disorders that arise due to a single faulty gene that 
fails to metabolically regulate a particular biochemical 
pathway.10 In IMD mutations occur in DNA coding for 
a precise protein, either enzyme, receptor, transport 
medium, membrane pump, or structural component. 11 
Although IEMs are discretely rare but they collectively 
have high incidence and may lead to considerable 
mortality or long-term morbidity. 12 Often, there is a 
pre-existing history of an affected child in the family of 
such patients. Current research data regarding IMDs 
in Pakistan has shown a significant prevalence and 
Non-ketotic hyperglycinemia is the topmost disorder.12 
The timely diagnosis of IEM and early initiation of 
specific treatment may be life-saving in these patients.  
The purpose of the current study was to screen and 
diagnose the distribution of different IEMs in infants 
coming to the tertiary care hospital both from rural 
and urban areas. We found a significant number of 
positive cases while conducting the test. In this 
screening study, 17% of clinically suspected cases were 
diagnosed to have metabolic disorders which are in 
accordance with the published data.14 G6PD disorder 
was found to be the Most disorder in 29.79% of 
diagnosed cases followed by Aminoaciduria 19.15%  
and Carnitine Uptake Defect 10.64%. Similar results 
were found by Gul et al except for Amino acid 
metabolism which they found as the most common 
defect in 33.33% of cases.15 Lodh and Kerketta quoted 
the incidence of G6PD deficiency and cystic fibrosis as 
24.18% and 6.59% respectively which are to some 
extent in agreement with our findings.14 Recently, a 
study carried out by Kaifi et al has highlighted the 
G6PD deficiency, Aminoaciduria, and Carnitine 
Uptake Defect as top-ranked IEMs though with 
different percentages.16 In another study Sharma et al 
also documented G6PD deficiency as the most 
prevalent disorder but contrary to our findings they 
reported a very high incidence of 44% of the total 
diagnosed cases.17 Cantu´-Reyna et al found  G6PD 
deficiency and hemoglobinopathies as the most 
frequent disorders.18  
Echeverri et al screened different IDM and listed 
aminoacidopathies as the commonest disorders 
followed by organic aciduria and Lysosomal storage 
disorders.19 In our study the most frequent disorder 
was G6PD deficiency which is in accordance with the 
global incidence. The variation of detection of different 
IMDs is of course due to ethnic and regional origin. In 
Spain, the only IMD detected in all communities is 
PKU. In the present picture, there is a severe need for a 
more screening program to find the epidemiological 
statistics about the disease burden. In our country, due 
to more number of consanguineous marriages and big 
family size, we assume that these metabolic diseases 
along with rare disorders are prevalent. Forty-seven 
(47) cases of 13 different disorders were diagnosed in 
our study. The diagnosis of inherited metabolic 
disorders is currently rising in Pakistan. Many factors 
including economical, educational, and unawareness 





The spectrum of inborn metabolic disorders is wide in 
our population and the cases detected to have IMEs 
revealed a significant prevalence. G6PD was detected 
as the most frequent disorder followed by 
Aminoaciduria and Carnitine Uptake Defect. There is 
more need to counsel the people about IMDs as well as 
developments in early screening for such disorders to 
protect them from future complications. A simple Heel 
prick test on PerkinElmer 226 filter paper is a useful 
method to detect IMDs, though confirmation is usually 
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